Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 188 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
Prairie Education and Research Cooperative-St. John's — Springfield, Illinois (2.2 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: NRG Oncology
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Springfield Clinic - First — Springfield, Illinois (2.2 mi)
· Sponsor: Eli Lilly and Company
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Central Illinois Hematology Oncology Center — Springfield, Illinois (2.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: SWOG Cancer Research Network
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Atherosclerosis, Coronary Artery Disease
Phase 2
Interventional 456 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Beijing Inno Medicine Co., Ltd.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: NRG Oncology
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Children's Oncology Group
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
Open Angle Glaucoma
Phase 4
Interventional 70 participants sought
Prairie Eye Center — Springfield, Illinois (2.2 mi)
· Sponsor: Prairie Eye Center
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: SWOG Cancer Research Network
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Prarie Education and Research — Springfield, Illinois (2.2 mi)
· Sponsor: Amgen
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Phase 2
Interventional 92 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
Phase 3
Interventional 350 participants sought
Ep0162 50375 — Springfield, Illinois (2.2 mi)
· Sponsor: UCB Biopharma SRL
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Urothelial Carcinoma
N/A
Interventional 94 participants sought
Southern Illinois University — Springfield, Illinois (2.2 mi)
· Sponsor: Case Comprehensive Cancer Center
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Hypertension
N/A
Interventional 261 participants sought
St. John's Prairie Heart — Springfield, Illinois (2.2 mi)
· Sponsor: SoniVie Inc.
Rural Illinois Lung Cancer Screening Initiative
Lung Cancer
N/A
Observational 10,000 participants sought
Sowmy Thuppal — Springfield, Illinois (2.2 mi)
· Sponsor: Southern Illinois University